SIGMAR1 and Parkinson disease: Taken together, the current study demonstrates the important role of Sigma1Rs in the neuroprotective effect of afobazole in the 6-OHDA model of Parkinson’s disease and suggests that the use of Sigma1R agonists could be beneficial as a Parkinson’s disease treatment.